HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial
Author(s)
Type
Journal Article
Abstract
Background: Effective interventions to reduce HIV incidence in sub-Saharan Africa are urgently needed. Mathematical
modelling and the HIV Prevention Trials Network (HPTN) 052 trial results suggest that universal HIV testing combined
with immediate antiretroviral treatment (ART) should substantially reduce incidence and may eliminate HIV as a public
health problem. We describe the rationale and design of a trial to evaluate this hypothesis.
Methods/Design: A rigorously-designed trial of universal testing and treatment (UTT) interventions is needed because:
i) it is unknown whether these interventions can be delivered to scale with adequate uptake; ii) there are many
uncertainties in the models such that the population-level impact of these interventions is unknown; and ii) there are
potential adverse effects including sexual risk disinhibition, HIV-related stigma, over-burdening of health systems, poor
adherence, toxicity, and drug resistance.
In the HPTN 071 (PopART) trial, 21 communities in Zambia and South Africa (total population 1.2 m) will be randomly
allocated to three arms. Arm A will receive the full PopART combination HIV prevention package including annual
home-based HIV testing, promotion of medical male circumcision for HIV-negative men, and offer of immediate ART
for those testing HIV-positive; Arm B will receive the full package except that ART initiation will follow current national
guidelines; Arm C will receive standard of care. A Population Cohort of 2,500 adults will be randomly selected in each
community and followed for 3 years to measure the primary outcome of HIV incidence. Based on model projections,
the trial will be well-powered to detect predicted effects on HIV incidence and secondary outcomes.
Discussion: Trial results, combined with modelling and cost data, will provide short-term and long-term estimates of
cost-effectiveness of UTT interventions. Importantly, the three-arm design will enable assessment of how much could
be achieved by optimal delivery of current policies and the costs and benefits of extending this to UTT.
modelling and the HIV Prevention Trials Network (HPTN) 052 trial results suggest that universal HIV testing combined
with immediate antiretroviral treatment (ART) should substantially reduce incidence and may eliminate HIV as a public
health problem. We describe the rationale and design of a trial to evaluate this hypothesis.
Methods/Design: A rigorously-designed trial of universal testing and treatment (UTT) interventions is needed because:
i) it is unknown whether these interventions can be delivered to scale with adequate uptake; ii) there are many
uncertainties in the models such that the population-level impact of these interventions is unknown; and ii) there are
potential adverse effects including sexual risk disinhibition, HIV-related stigma, over-burdening of health systems, poor
adherence, toxicity, and drug resistance.
In the HPTN 071 (PopART) trial, 21 communities in Zambia and South Africa (total population 1.2 m) will be randomly
allocated to three arms. Arm A will receive the full PopART combination HIV prevention package including annual
home-based HIV testing, promotion of medical male circumcision for HIV-negative men, and offer of immediate ART
for those testing HIV-positive; Arm B will receive the full package except that ART initiation will follow current national
guidelines; Arm C will receive standard of care. A Population Cohort of 2,500 adults will be randomly selected in each
community and followed for 3 years to measure the primary outcome of HIV incidence. Based on model projections,
the trial will be well-powered to detect predicted effects on HIV incidence and secondary outcomes.
Discussion: Trial results, combined with modelling and cost data, will provide short-term and long-term estimates of
cost-effectiveness of UTT interventions. Importantly, the three-arm design will enable assessment of how much could
be achieved by optimal delivery of current policies and the costs and benefits of extending this to UTT.
Date Issued
2014-02-13
Date Acceptance
2014-02-03
Citation
Trials, 2014, 15 (1)
ISSN
1745-6215
Publisher
BioMed Central
Journal / Book Title
Trials
Volume
15
Issue
1
Copyright Statement
© 2014 Hayes et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Sponsor
Medical Research Council (MRC)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333469600004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
MR/K010174/1B
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, Research & Experimental
Research & Experimental Medicine
SIMPLEX-VIRUS TYPE-2
ANTIRETROVIRAL THERAPY
MALE CIRCUMCISION
SEXUAL TRANSMISSION
RURAL TANZANIA
SOUTH-AFRICA
VIRAL LOAD
INFECTION
RISK
STRATEGY
Adolescent
Adult
Anti-HIV Agents
Circumcision, Male
Clinical Protocols
Cost-Benefit Analysis
Drug Administration Schedule
Female
HIV Infections
Health Care Costs
Humans
Incidence
Male
Mass Screening
Predictive Value of Tests
Prevalence
Research Design
South Africa
Time Factors
Treatment Outcome
Young Adult
Zambia
HPTN 071 (PopART) Study Team
1102 Cardiovascular Medicine And Haematology
1103 Clinical Sciences
Cardiovascular System & Hematology
General & Internal Medicine
Publication Status
Published
Article Number
ARTN 57